PsyMuKB

PPI network (data source: BioGrid)

A gene is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the mean normalized expression(base 2 log of (TPM+1)) +1 in all brain tissue from GTEx v7 or BrainSpan data.

A protein is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the normalized expression (base 10 log of iBAQ intensity) ≥0.5 in at least one brain tissue from ProteomicsDB data. Otherwise, a gene or protein is determined as either with below-cutoff expressions or no available data.

	The queried gene/protein
	The interacting partner is expressed at mRNA-level
	The interacting partner is expressed at protein-level
	The interacting partner is expressed at both mRNA and protein level
	The interacting partner is with either below-cutoff expressions or no expression data at both mRNA and protein level
	The interacting partner is hit by coding DNMs
	Physical interaction between queried gene/protein and its partner
	Physical interaction between two interacting partners

Symbol A	GeneA coding DNM count	Symbol B	GeneB coding DNM count	Interaction detection method	Publication	Evidence
PRMT5	3	HIST2H2AC	1	enzymatic study	Amente S (2005)	1
MYSM1	3	HSPA1A	0	affinity chromatography technology	Zhu P (2007)	1
KAT2B	2	KIF11	5	affinity chromatography technology	Zhu P (2007)	1
MYSM1	3	KAT2B	2	affinity chromatography technology, affinity chromatography technology	Zhu P (2007), Zhu P (2007)	2
HIST2H2AC	1	UBC	7	pull down, pull down	Long L (2014), Zhang X (2017)	2
EEF1A1	0	HSPA1A	0	biochemical	Havugimana PC (2012)	1
MYSM1	3	WDR77	2	affinity chromatography technology	Zhu P (2007)	1
MYSM1	3	PRMT5	3	affinity chromatography technology	Zhu P (2007)	1
MYSM1	3	HNRNPH1	3	affinity chromatography technology	Zhu P (2007)	1
MYSM1	3	STK38	0	affinity chromatography technology	Zhu P (2007)	1
PRMT5	3	WDR77	2	affinity chromatography technology, affinity chromatography technology, pull down, pull down, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, pull down, two hybrid, two hybrid, biochemical, biochemical, biochemical, two hybrid, affinity chromatography technology	Friesen WJ (2002), Friesen WJ (2002), Friesen WJ (2002), Friesen WJ (2002), Liu F (2011), Aggarwal P (2010), Aggarwal P (2010), Patel SR (2012), Patel SR (2012), Hosohata K (2003), Hegele A (2012), Hegele A (2012), Antonysamy S (2012), Kristensen AR (2012), Wan C (2015), Lacroix M (2008), Saha K (2016)	17
UBC	7	WDR77	2	affinity chromatography technology	Matsumoto M (2005)	1
UBC	7	HNRNPH1	3	affinity chromatography technology	Matsumoto M (2005)	1
MYSM1	3	HIST2H2AC	1	affinity chromatography technology, enzymatic study, enzymatic study	Zhu P (2007), Zhu P (2007), Draker R (2011)	3
MYSM1	3	RBM10	1	affinity chromatography technology	Zhu P (2007)	1
MYSM1	3	EEF1A1	0	affinity chromatography technology	Zhu P (2007)	1
MYSM1	3	UBC	7	affinity chromatography technology	Zhu P (2007)	1
STK38	0	HIST2H2AC	1	enzymatic study	Campos EI (2015)	1
MYSM1	3	TUBB1	1	affinity chromatography technology	Zhu P (2007)	1
DICER1	4	MYSM1	3	affinity chromatography technology	Li S (2014)	1
MYSM1	3	KIF11	5	affinity chromatography technology	Zhu P (2007)	1
KAT2B	2	HIST2H2AC	1	enzymatic study	Yang XJ (1996)	1